Afferent Pharmaceuticals

About:

Afferent Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines to treat chronic pain.

Website: http://www.afferentpharma.com

Top Investors: Fidelity, Redmile Group, Third Rock Ventures, Domain Associates, New Leaf Venture Partners

Description:

Afferent Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It develops medicines to treat chronic pain by targeting P2X3 receptors in nerve fibers. The company’s AF-219, a compound that completed two Phase 1 clinical studies. Afferent Pharmaceuticals, Inc. was founded in 2009 and is based in San Mateo, California.